0001193125-26-296597.txt : 20260706 0001193125-26-296597.hdr.sgml : 20260706 20260706193652 ACCESSION NUMBER: 0001193125-26-296597 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260706 FILED AS OF DATE: 20260706 DATE AS OF CHANGE: 20260706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYDEN JEREMY B. CENTRAL INDEX KEY: 0001650737 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40587 FILM NUMBER: 261157474 MAIL ADDRESS: STREET 1: 2 MUSICK STREET 2: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sight Sciences, Inc. CENTRAL INDEX KEY: 0001531177 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 800625749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4040 CAMPBELL AVE, STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (415) 889-0550 MAIL ADDRESS: STREET 1: 4040 CAMPBELL AVE, STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 ownership.xml 4 X0609 4 2026-07-06 0001531177 Sight Sciences, Inc. SGHT 0001650737 HAYDEN JEREMY B. false C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE., SUITE 100 MENLO PARK CA 94025 false true false false Chief Legal Officer true Common Stock 2026-07-06 4 S false 12733 5.508 D 357037 D Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 100,015 shares of Common Stock, and (ii) 257,022 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. /s/Jeremy B. Hayden 2026-07-06